Platform
Two powerful tools. One seamless pathway.
From population-level risk estimation to precision in-person screening, CardiAction's platform covers the full cardiovascular health assessment journey.
ProScreen
In-Clinic ScreeningIn-person heart and artery health screening using the TGA-registered, FDA-cleared Uscom BP+ Pulse Wave Analysis device. Direct measurement of central blood pressure, arterial stiffness, and haemodynamic parameters.
- In-clinic heart and artery health screening
- TGA-registered, FDA-cleared Pulse Wave Analysis device
- Direct measurement of central blood pressure and arterial stiffness
- Instant results with personalised action plan
PreScreen
Online PredictionOnline cardiovascular risk screening tool validated by Griffith University (R=0.785, P<0.001). Estimates central systolic blood pressure from self-reported biometrics.
- Online cardiovascular risk prediction
- Uses key biometrics — no blood test, no clinic visit
- Estimates central blood pressure and risk score
- Categorises risk as low, moderate, or elevated
What ProScreen Adds Beyond Standard Screening
Parameter
Standard BP Check
ProScreen
Brachial blood pressure
Central systolic blood pressure
Augmented pressure
Central pulse pressure
Arterial stiffness indicators
Heart rate assessment
Irregular heartbeat detection
Sometimes
Personalised action plan
Progress tracking
Ready to bring CardiAction to your organisation?
Whether you are a pharmacy group, government health agency, health insurer, or clinical organisation, we welcome the opportunity to discuss how CardiAction can support your cardiovascular prevention strategy.